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Abstract: Patient reported outcomes (PRO) are an important component of treatment evaluation.
Typically, PROs are completed by patients on paper, however through advances in
technology, such as mobile phone apps and websites, there is great opportunity for
electronic completion. It can be challenging particularly at a regional or national level to
maintain accurate core clinical head and neck cancer (HNC) records; baseline,
recurrence, second primary, and further treatments. These will influence PRO and
outcomes reporting. In addition, with data security and confidentiality, there is merit in
undertaking anonymous surveys but in this approach, there is a reliance on patient
recall. The aim of this study was to compare updated hospital records with details
completed by patients. In January 2019, 395 HNC patients treated in 2015 and 2016
were sent a survey. They were asked to recall clinical variables of gender, age at
diagnosis, tumour site, tumour stage and primary treatment and these were analysed
for agreement with hospital records. The Kappa statistic (KP) was used to measure
strength of agreement for categorical variables. There were 146 responders with one
patient correctly stating they did not have cancer. Five patients indicated further
disease rather than primary cancer within the selection cohort of 2015-16. Agreement
between hospital record and patient recall was excellent for gender (KP=0.97) and
age-group (KP=0.92), very good for treatment (KP=0.79), good for site of cancer
(KP=0.61) but poor for stage of cancer (KP=0.18). Conclusion: In general patients give
accurate accounts of these HNC details apart from tumour staging.
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Patient reported outcomes (PRO) are an important component of treatment evaluation. 
Typically, PROs are completed by patients on paper, however through advances in 
technology, such as mobile phone apps and websites, there is great opportunity for electronic 
completion. It can be challenging particularly at a regional or national level to maintain 
accurate core clinical head and neck cancer (HNC) records; baseline, recurrence, second 
primary, and further treatments. These will influence PRO and outcomes reporting. In 
addition, with data security and confidentiality, there is merit in undertaking anonymous 
surveys but in this approach, there is a reliance on patient recall. The aim of this study was to 
compare updated hospital records with details completed by patients. In January 2019, 395 
HNC patients treated in 2015 and 2016 were sent a survey. They were asked to recall clinical 
variables of gender, age at diagnosis, tumour site, tumour stage and primary treatment and 
these were analysed for agreement with hospital records. The Kappa statistic (KP) was used 
to measure strength of agreement for categorical variables. There were 146 responders with 
one patient correctly stating they did not have cancer. Five  patients indicated further disease 
rather than primary cancer within the selection cohort of 2015-16. Agreement between 
hospital record and patient recall was excellent for gender (KP=0.97) and age-group 
(KP=0.92), very good for treatment (KP=0.79), good for site of cancer (KP=0.61) but poor 
for stage of cancer (KP=0.18). Conclusion: In general patients give accurate accounts of these 





Accurate data is essential when reporting treatment outcomes. For some countries large 
datasets exist; for example German-Austrian-Swiss Cooperative Group on Tumours of the 
Maxillofacial Region (DÖSAK),1  Danish Head and Neck Cancer Group (DAHANCA),2 
National Cancer Database,3 US population using Surveillance, Epidemiology, and End 
Manuscript with title (excluding any author details including
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Results (SEER),4 whilst other centres collect regional data related to their unit such as 
Copenhagen,5 and Liverpool.6 Accurate data is more difficult to maintain for regional centres 
as they have a wider geographic referral base into the centre and follow-up tends to be in the 
patients locality. Good data relies on the flow of information especially when subsequent 
follow-up is at a distant unit. It is time consuming and relatively expensive to maintain 
accurate data. Potential inaccuracy occurs when amalgamating different sources of data and 
agreeing any discrepancies can be time consuming.  Also, there is workload associated with 
manually extracting data from clinical records.  
 
Patient reported outcomes (PRO) augment head and neck cancer (HNC) survival outcomes, 
and are important for case mix adjustment.7 PRO are usually completed by the patient using 
paper or electronic devices and it gives their perspective of function and dysfunction.8 
Collating the clinical characteristics and linking these to individual patients in an ‘audit’ 
setting rather than dedicated trials research funded projects can be challenging. 
 
Although the core clinical characteristics might be recorded at tumour board / multi 
professional team meeting, it is possible that the treatment decision of the MDT is not 
ultimately delivered. Failure to update the treatment record can be a source of error 
particularly if the oncology and surgical departments provide treatment at different sites and 
do not share the same patient record system. It can also be hard to update patients records in 
respect to events such as recurrence, second primaries, significant comorbidity, and further 
treatments. 
 
If patients can accurately report their core clinical characteristics, this would be useful in 
anonymous surveys where the patient is not linked to any existing dataset.  Anonymous data 
supports General Data Protection Regulation (GPD) as the use of personal data apart from 
patient identification is minimised. Although patients and carers are given a lot of 
information at the time of diagnosis and treatment planning and generally appear to be 
satisfied, there is still considerable variability in how the information is understood 9 and little 
evidence in the literature of how well this is retained over time. Key patient characteristics in 
the management of HNC include gender, age, year of diagnosis, site of cancer, stage of 
cancer, treatment, recurrence, and second primary.  
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The aim of this paper was to compare patient characteristics as derived from the clinical 
record with patient data derived from a postal survey. The intention was to measure 
agreement and to explore in greater depth any discrepancies. It was hoped to indicate which 
patient derived data can be trusted as being accurate from a postal survey. This has 
implications for research projects to alleviate the workload in manually extracting data from 
clinical records and also data submitted by patients via online internet surveys. 
 
Method 
For this study we identified patients treated for primary head and neck squamous cell 
carcinomas in the Aintree Regional Maxillofacial Unit between January 2015 and December 
2016 and who were alive in January 2019. These patients were surveyed in early 2019 on the 
topic of loneliness and this is reported elsewhere.10 Patients with cutaneous and salivary 
gland malignancy, treated with palliative intent, with cognitive impairment or living overseas 
were excluded. Clinical and demographic data, comprising gender, age at diagnosis, tumour 
site, tumour stage and primary treatment were collected from the clinical record.  In the 
postal survey patients were asked in what year they were born (free text), to which gender 
they most identified (male, female, prefer not to say), the year of their first diagnosis (free 
text), the site of the cancer when first diagnosed (oral [mouth], laryngeal [voice box], 
oropharyngeal [throat-tonsil, soft palate, base of tongue]) , the stage of cancer (early [stage 1 
or 2], advanced [Stage 3 or 4]), the treatments received (surgery, radiotherapy, 
chemotherapy).  
 
The Kappa coefficient of agreement was used to measure the total sample level of agreement 
between categorical patient derived and clinical record data. The McNemar test (2 categories) 
and McNemar-Bowker test (more than 2 categories) were used  to test for systematic 
disagreement between the two sources of information.  
 




There were 146 responders to the survey from a denominator of 395 known survivors, a 
response rate of 37%. Five patients indicated that their primary cancer treatment was earlier 
(1998, 2003, 2004, 2010, 2011) than the 2015-2016 cohort selected for the survey using 
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clinical records and they indicated further disease within the selected cohort.  One patient 
stated there was no diagnosis of cancer and indicated a non-cancer diagnosis in 2010.    
 
Regarding patient gender the agreement was excellent (Kappa statistic 0.97), with just two 
discrepancies, though on further inspection the database was correct.  Patient age at diagnosis 
was derived from clinical records using date of diagnosis and date of birth, whereas the 
survey asked for year of diagnosis and year of birth. There was agreement within one year of 
age for 90% (131/146) of patients; of the 15 patient age discrepancies, 5 stated a primary 
diagnosis before 2015, 1 stated a non-cancer diagnosis in 2010, 6 had age discrepancies of 
less than 2 years and 3  had discrepancies of 2.2, 2.3 and 20 years. Regarding patient age 
group (<55, 55-64, 65-74, ≥75) at diagnosis (Table 1) there was excellent overall agreement 
(Kappa statistic 0.92), with eight discrepancies between categories of which 3 were patients 
stating a primary diagnosis before 2015 and 1 with a non-cancer diagnosis in 2010.  
 
Patients were asked to categorise the site of their cancer when first diagnosed as oral (mouth), 
laryngeal (voice box), oropharyngeal (throat-tonsil, soft palate, base of tongue), other site, 
unsure (Table 2). Three patients were unsure and did not state a site while three selected more 
than one category.  The overall kappa statistic of 0.61 represents a good level of agreement 
with the clinical record; the exclusion of the six ‘out of cohort’ patients gave a kappa statistic 
of 0.62. However, there were 39 discrepancies in all, including 13 between oral and 
oropharynx and 8 between larynx and oropharynx.  
 
Patients were asked to categorise the stage of their cancer when first diagnosed as early (stage 
1 or 2), advanced (stage 3 or 4) or unsure (Table 3). In categorising the clinical record into 
early and late staging priority was given to pathology data when available over clinical 
staging. The overall kappa statistic of 0.18 represents a poor level of agreement and the 
significant McNemar-Bowker test (p<0.001) indicates systematic differences between 
clinically derived patient survey data. The predominant discrepancy (38 patients) was for the 
clinically derived staging to be advanced and for the patient to regard it as early; the 
discrepancy the other way round (clinical early, patient advanced) was seen for only three 
patients. There were 81 discrepancies in all.  
 
Patients were asked to indicate what treatments (surgery, radiotherapy, chemotherapy) they 
received when first diagnosed with cancer (Table 4). The overall kappa statistic of 0.79 
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borders on a very good level of agreement; the exclusion of the six ‘out of cohort’ patients 
gave a kappa statistic of 0.81. There were 20 discrepancies in all. 
 
Discussion 
Maintaining correct HNC data over time is a challenge. However, with the wider use of smart 
phone technology and electronic patient records it is possible in future for patients themselves 
to help validate accuracy. For patient surveys, in terms of data confidentiality, there is merit 
in anonymous data collection. This relies on patient recall and understanding of their clinical 
characteristics. The findings might be different in other centres and countries.  Unfortunately, 
the response rate was less than ideal but sufficient to gain an overall impression. As the 
survey was designed in the context of ‘audit’ no reminders were sent. The study was part of 
another survey on loneliness and quality of life 10 so perhaps the number of questionnaires 
and topic deterred patients from responding. Caution needs to be applied when interpreting 
and generalising these data since the responders perhaps were more knowledgeable about 
their clinical characteristics than those choosing not to respond. The awareness of patient 
cancer characteristics might be related to educational level and this was not recorded. It is not 
possible to know exactly what these patients were told at diagnosis, their understanding, and 
to what extent there was loss of recall over time. A larger study over a longer period would 
be required in order to comment on patient accuracy in regard to recurrence and second 
primaries.  
   
The study would suggest that patient response to a paper survey was sufficiently accurate for 
age, gender, and treatment. The survey revealed clerical errors in the departmental dataset, 
particularly in regard to distinguishing between new cancers and previous disease. Despite 
attempts to be vigilant about recording all HNC patients it is possible also that some eligible 
patients might have been missed.   In regard to gender, the two survey discrepancies were 
found to reflect patient error, which highlights mistakes that can occur either by ticking the 
wrong box or transcribing from questionnaire to database. Regarding age, to avoid patient 
identifiers the survey only asked for year of birth and the year of diagnosis; hospital records 
contained full date of birth and diagnosis. Consequently, there were minor discrepancies 
between age at diagnosis between hospital and survey data, most of which were consistent 
with this difference in precision. In a small number of cases some patients were placed within 
different age groups if they were close to age cut-offs. Further investigation of the patient 
with a 20 year discrepancy indicated the hospital database to be correct, the error occurring 
 6 
because of illegibility of the year of birth on the survey form.  There was some disagreement 
in relation to site and this tended to relate to when anatomical site touched or overlapped such 
as oral to oropharynx, oropharynx to larynx. There was relatively poor agreement in respect 
to stage with patients tending to consider themselves having earlier disease, and we are not 
sure why this was the case; further qualitative research would be helpful. There was complete 
agreement regarding those patients having single modality treatment, i.e. surgery alone or 
non-surgical treatment alone. For those with multi modal treatments it can be difficult to 
maintain accuracy because some patients will be selected for post-operative radiotherapy 
following surgery but for a variety of reasons have surgery alone; other patients might 
consider a tumour biopsy as being part of a surgical intervention even though they were 
managed non-surgically.  
 
In order to have confidence in patient recollection of characteristics further research is 
required. It would be useful to ask about HPV status given its prognostic importance, though 
discussion around HPV can be awkward.11 It is incumbent on those responsible for patient 
data to explore ways to allow patients themselves to contribute to the reliability of their data. 
This might be improved through careful explanations of stage, site or the use of diagrams 
with patients having an individualised summary of their cancer characteristics for their own 
record. 
 
In conclusion, patients can help to validate their HNC data and any discrepancies clarified. 
Anonymous data would allow large patient cohorts for the purpose of patient reported 
outcomes; however, there is a need to have stronger evidence of accurate patient recall before 
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Total  <55  55-64  65-74  75+ 
Clinical 
record 
<55 27 - - - 27 
55-64 1 50 1 - 52 
65-74 1 - 43 2 46 
75+ - 1 2 18 21 
Total 29 51 46 20 146 
















Oral 38 - 8  3 2 - 51 
Laryngeal 1 9 8 1 - 2 21 
Oropharyngeal 5 - 51 2 1 - 59 
Other 3 1 1 9 - 1 15 
Total 47 10 68 15 3 3 146 
Overall: Kappa statistic 0.607 (SE 0.051)  








Total  Early  Advanced Not stated 
Clinical 
record 
Early 46 3 8 57 
Advanced 38 18 32 88 
Total 84 21 40 145 
 
One patient who said there was no cancer diagnosis did not answer this question. 
 
Overall: Kappa statistic 0.184 (SE 0.041) 
When patient stated Early or Advanced: Kappa statistic 0.249 (SE 0.071). McNemar test p<0.001 
 
 




Total Surgery only  CT/RT only  Surgery + CT/RT 
Clinical 
record 
Surgery only 49* - 6  55 
CT/RT only - 36 3 39 
Surgery + CT/RT 6  5 41 52 
Total 55 41 50 146 
Overall: Kappa statistic 0.793 (SE 0.043). McNemar-Bowker test p=0.78 
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